Anti-Human CD7 Antibody
英诺赛图(InnoCyto)的 Anti-Human CD7 Antibody(克隆 Grisnilimab) 为人源 IgG1 单克隆抗体,靶向 CD7(别名 gp40),Purified 标记,适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥475 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 Anti-Human CD7 Antibody(克隆 Grisnilimab) 为人源 IgG1 单克隆抗体,靶向 CD7(别名 gp40),Purified 标记,适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥475 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
118801 | 25 μg | ¥475
118802 | 100 μg | ¥680
Product Details
Regulatory Status|RUO
Protein Concentration|0.5 mg/mL
Storage & Handling|The antibody solution should be stored between 2°C and 8°C
Recommended Usage|For flow cytometric staining, it is recommended to use less than 0.2 µg of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application
See All Formats|Clone Grisnilimab
Background Information
Human CD7 is a 40-kDa type I transmembrane glycoprotein and one of the earliest surface markers expressed during T-cell development. It is present on the majority of mature T cells and natural killer (NK) cells, as well as on early lymphoid and some myeloid progenitors. CD7 belongs to the immunoglobulin superfamily and contains a single extracellular immunoglobulin-like domain, a transmembrane region, and a short cytoplasmic tail containing signaling motifs. CD7 contributes to T-cell and NK-cell activation, adhesion, and cytokine production, functioning primarily as a costimulatory molecule that can amplify signals generated through the T-cell receptor.
The best-characterized ligand for human CD7 is secreted and transmembrane protein 1 (SECTM1), which exists in both membrane-bound and soluble forms. Interaction between SECTM1 and CD7 can promote T-cell proliferation and enhance cytokine production, including interferon-γ and IL-2, particularly in cooperation with other costimulatory signals.
CD7 itself is not generally considered a disease-causing molecule, but its expression pattern makes it an important biomarker and therapeutic target in hematological malignancies. CD7 is expressed in more than 95% of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL), and is also present in subsets of peripheral T-cell lymphomas and acute myeloid leukemia.
Therapeutically, CD7 is being extensively investigated as a target for monoclonal antibodies, antibody-drug conjugates, immunotoxins, and particularly CAR-T-cell therapy. CD7 CAR-T cells have shown promising responses in relapsed or refractory T-ALL/LBL and other CD7-positive malignancies. A major challenge is “fratricide,” because normal T cells and the engineered CAR-T cells themselves express CD7. Gene editing, protein masking, and other engineering strategies are therefore being developed to prevent CAR-T self-killing and improve treatment durability.
Data Sheets
Human peripheral blood lymphocytes were stained with PB Anti-Human CD3 clone UCHT1 and Purified Anti-Human CD7 biosimilar Grisnilimab (left) or an isotype control (right), followed by PE Anti-Human IgG.
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). Anti-Human CD7 Antibody(118801)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/anti-human-cd7-antibody-118801.html.
TeleVM. (2026, November 12). Anti-Human CD7 Antibody(118801). 产品目录. https://www.suprotek.cn/products/item/anti-human-cd7-antibody-118801.html
@misc{biocsp_item_anti_human_cd7_antibody_118801,
title = {Anti-Human CD7 Antibody(118801)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/anti-human-cd7-antibody-118801.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源